Women’s health therapeutics market backed by a strong pipeline expected to drive growth

Abbott will gain full control of two drugs Tricor (fenofibrate) and Trilipix (fenofibric acid), for treating cholesterol and triglycerides. For more information on the women’s health therapeutics market, see the latest research: Women’s Health Therapeutics Market

Posted in Uncategorized